|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5.020 HKD | -1.57% |
|
+1.01% | -0.59% |
Company Valuation: Alibaba Health Information Technology Limited
Data adjusted to current consolidation scope
| Fiscal Period: March | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Capitalization 1 | 249,895 | 55,546 | 67,155 | 47,224 | 70,650 | 71,214 | - | - |
| Change | - | -77.77% | 20.9% | -29.68% | 49.61% | 0.8% | - | - |
| Enterprise Value (EV) 1 | 238,259 | 45,133 | 56,315 | 37,753 | 62,849 | 59,903 | 56,923 | 53,499 |
| Change | - | -81.06% | 24.78% | -32.96% | 66.47% | -4.69% | -4.97% | -6.01% |
| P/E ratio | 708x | -209x | 126x | 46.8x | 49.5x | 30x | 25.1x | 21.5x |
| PBR | 17.2x | 3.93x | 4.43x | 2.83x | 4.33x | 3.8x | 3.31x | 2.86x |
| PEG | - | 1x | -0x | 0.8x | 1.2x | 0.5x | 1.3x | 1.3x |
| Capitalization / Revenue | 16.1x | 2.7x | 2.51x | 1.75x | 2.31x | 2.02x | 1.8x | 1.64x |
| EV / Revenue | 15.4x | 2.19x | 2.1x | 1.4x | 2.05x | 1.7x | 1.44x | 1.23x |
| EV / EBITDA | 529x | -43.7x | 1,764x | 54.4x | 40.9x | 25x | 19.6x | 15.6x |
| EV / EBIT | 539x | -41.2x | -1,772x | 59x | 42.5x | 25.5x | 19.8x | 15.5x |
| EV / FCF | 246x | 110x | 225x | 35.7x | - | 23.8x | 19.5x | 15x |
| FCF Yield | 0.41% | 0.91% | 0.44% | 2.8% | - | 4.21% | 5.13% | 6.65% |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | 0.0262 | -0.0197 | 0.0394 | 0.0627 | 0.0888 | 0.1468 | 0.1755 | 0.2044 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | 15,518 | 20,578 | 26,763 | 27,027 | 30,598 | 35,241 | 39,500 | 43,429 |
| EBITDA 1 | 450.2 | -1,034 | 31.93 | 693.9 | 1,536 | 2,394 | 2,897 | 3,440 |
| EBIT 1 | 442.1 | -1,094 | -31.79 | 640.2 | 1,479 | 2,346 | 2,868 | 3,445 |
| Net income 1 | 348.6 | -265.6 | 533.4 | 883.5 | 1,432 | 2,309 | 2,758 | 3,237 |
| Net Debt 1 | -11,637 | -10,412 | -10,839 | -9,471 | -7,801 | -11,312 | -14,291 | -17,715 |
| Reference price 2 | 18.541 | 4.112 | 4.970 | 2.937 | 4.393 | 4.405 | 4.405 | 4.405 |
| Nbr of stocks (in thousands) | 13,477,663 | 13,507,505 | 13,511,061 | 16,081,435 | 16,082,550 | 16,164,999 | - | - |
| Announcement Date | 25/05/21 | 25/05/22 | 23/05/23 | 27/05/24 | 19/05/25 | - | - | - |
1CNY in Million2CNY
Estimates
P/E ratio, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
| 30.49x | 1.73x | 25.49x | -.--% | 10.53B | ||
| 28.05x | 1.49x | 24.13x | -.--% | 20.36B | ||
| 16.85x | 0.75x | 7.76x | 2.01% | 6.04B | ||
| 17.11x | 1.11x | 7.87x | 2.36% | 4.32B | ||
| 19.28x | 1.23x | 8.72x | 3.37% | 4.05B | ||
| 16.94x | 1.49x | 8.9x | 5.09% | 3.69B | ||
| 18.54x | 0.73x | 6.15x | 3.03% | 3.18B | ||
| 31x | - | - | - | 2.11B | ||
| 23.5x | 0.72x | 9x | 1.72% | 1.72B | ||
| Average | 22.42x | 1.16x | 12.25x | 2.2% | 6.22B | |
| Weighted average by Cap. | 24.52x | 1.34x | 17.51x | 1.25% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Equities
- 241 Stock
- Valuation Alibaba Health Information Technology Limited
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition
















